Join NBTS’s campaign to raise awareness about the importance of biomarker testing and clinical trials for patients with brain tumors.
READ MORE
On the fifth annual Glioblastoma Awareness Day, July 19, 2023, we shine a light on glioblastoma (GBM), the most common, complex, treatment-resistant, and deadliest type of brain cancer.
National Brain Tumor Society spearheaded this annual event in 2019 to support survivors and their loved ones, to remember those who are no longer with us, and to honor luminaries working toward a cure and better quality of life for those who are living with this devastating disease.
who will receive a glioblastoma diagnosis in 2023
is the five-year survival rate for glioblastoma patients
will succumb to glioblastoma this year
have been approved by the FDA — and one device — specifically for glioblastoma
This July, start a #GBMDay fundraiser to honor a loved one and make an impact for the brain tumor community.
